New concepts in management of otospongiosis.
D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D003051:Cochlea / Q000503:physiopathology; D005459:Fluorides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D010040:Otosclerosis / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D011138:Polytetrafluoroethylene; D011182:Postoperative Care; D019736:Prostheses and Implants / Q000009:adverse effects / Q000379:methods; D013193:Stainless Steel / Q000009:adverse effects; D013201:Stapes Surgery / Q000379:methods*; D014182:Transplantation, Autologous; D014680:Veins / Q000637:transplantation*
D013193:Stainless Steel; D011138:Polytetrafluoroethylene; D005459:Fluorides; D001241:Aspirin